Novel Metabolic Signatures of Prostate Cancer Revealed by <sup>1</sup>H-NMR Metabolomics of Urine

Novel Metabolic Signatures of Prostate Cancer Revealed by <sup>1</sup>H-NMR Metabolomics of Urine

Prostate cancer (PC) is one of the most common male cancers worldwide. Until now, there is no consensus about using urinary metabolomic profiling as novel biomarkers to identify PC. In this study, urine samples from 50 PC patients and 50 non-cancerous individuals (control group) were collected. Base...

Bibliografski detalji
Glavni autori:	Bo Yang, Chuan Zhang, Sheng Cheng, Gonghui Li, Jan Griebel, Jochen Neuhaus
Format:	Članak
Jezik:	English
Izdano:	MDPI AG 2021-01-01
Serija:	Diagnostics
Teme:	prostate cancer urine metabolomics <sup>1</sup>H-Nuclear Magnetic Resonance metabolite biomarkers
Online pristup:	https://www.mdpi.com/2075-4418/11/2/149

Slični predmeti

Untargeted Urinary <sup>1</sup>H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer Detection
od: Catarina L. Silva, i dr.
Izdano: (2019-11-01)

A Comparative Study of Rat Urine <sup>1</sup>H-NMR Metabolome Changes Presumably Arising from Isoproterenol-Induced Heart Necrosis Versus Clarithromycin-Induced QT Interval Prolongation
od: Matthieu Dallons, i dr.
Izdano: (2020-05-01)

Characterizing Marathon-Induced Metabolic Changes Using <sup>1</sup>H-NMR Metabolomics
od: Rachelle Bester, i dr.
Izdano: (2021-09-01)

<sup>1</sup>H-NMR Metabolomics as a Tool for Winemaking Monitoring
od: Inès Le Mao, i dr.
Izdano: (2021-11-01)

Urinary <sup>1</sup>H-NMR Metabolic Signature in Subjects Undergoing Colonoscopy for Colon Cancer Diagnosis
od: Cristina Piras, i dr.
Izdano: (2020-08-01)

Application of <sup>1</sup>H-NMR Metabolomics for the Discovery of Blood Plasma Biomarkers of a Mediterranean Diet
od: Shirin Macias, i dr.
Izdano: (2019-09-01)

Exercise and Interorgan Communication: Short-Term Exercise Training Blunts Differences in Consecutive Daily Urine <sup>1</sup>H-NMR Metabolomic Signatures between Physically Active and Inactive Individuals
od: Leon Deutsch, i dr.
Izdano: (2022-05-01)

<sup>1</sup>H-NMR Metabolomics Analysis of the Effects of Sulfated Polysaccharides from Masson Pine Pollen in RAW264.7 Macrophage Cells
od: Fangchen Su, i dr.
Izdano: (2019-05-01)

Urine and Fecal <sup>1</sup>H-NMR Metabolomes Differ Significantly between Pre-Term and Full-Term Born Physically Fit Healthy Adult Males
od: Leon Deutsch, i dr.
Izdano: (2022-06-01)

Fecal <sup>1</sup>H-NMR Metabolomics: A Comparison of Sample Preparation Methods for NMR and Novel in Silico Baseline Correction
od: Catherine L. J. Brown, i dr.
Izdano: (2022-02-01)

An Untargeted Metabolomics Investigation of Milk from Dairy Cows with Clinical Mastitis by <sup>1</sup>H-NMR
od: Chenglin Zhu, i dr.
Izdano: (2021-07-01)

Cluster Analysis Statistical Spectroscopy for the Identification of Metabolites in <sup>1</sup>H NMR Metabolomics
od: Silke S. Heinzmann, i dr.
Izdano: (2022-10-01)

<sup>1</sup>H-NMR Metabolomics Analysis of the Effect of Rubusoside on Serum Metabolites of Golden Hamsters on a High-Fat Diet
od: Li Li, i dr.
Izdano: (2020-03-01)

Metabolomic Analysis of Multiple Biological Specimens (Feces, Serum, and Urine) by <sup>1</sup>H-NMR Spectroscopy from Dairy Cows with Clinical Mastitis
od: Chenglin Zhu, i dr.
Izdano: (2023-02-01)

Dominant Components of the Giant Panda Seminal Plasma Metabolome, Characterized by <sup>1</sup>H-NMR Spectroscopy
od: Chenglin Zhu, i dr.
Izdano: (2022-06-01)

1H-NMR-based urine metabolomics of prostate cancer and benign prostatic hyperplasia
od: Mohammed Zniber, i dr.
Izdano: (2024-04-01)

Comparison of Hepatic Metabolite Profiles between Infant and Adult Male Mice Using <sup>1</sup>H-NMR-Based Untargeted Metabolomics
od: Doyoung Kwon, i dr.
Izdano: (2022-09-01)

Detection and Quantification of Ammonia as the Ammonium Cation in Human Saliva by <sup>1</sup>H NMR: A Promising Probe for Health Status Monitoring, with Special Reference to Cancer
od: Mohammed Bhogadia, i dr.
Izdano: (2023-06-01)

<sup>1</sup>H NMR Metabolomics of Chinese Human Milk at Different Stages of Lactation among Secretors and Non-Secretors
od: Maaria Kortesniemi, i dr.
Izdano: (2022-08-01)

[<sup>177</sup>Lu]Lu-PSMA-617 (Pluvicto<sup>TM</sup>): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer
od: Ute Hennrich, i dr.
Izdano: (2022-10-01)

[<sup>89</sup>Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Prior Indetermined Findings on [<sup>18</sup>F]PSMA-1007 Imaging
od: Moritz B. Bastian, i dr.
Izdano: (2024-10-01)

<sup>1</sup>H-NMR Metabolomic Study of the Mushroom <i>Pleurotus djamor</i> for the Identification of Nematocidal Compounds
od: Jesús Antonio Pineda-Alegría, i dr.
Izdano: (2024-04-01)

Theragnostic Radionuclide Pairs for Prostate Cancer Management: <sup>64</sup>Cu/<sup>67</sup>Cu, Can Be a Budding Hot Duo
od: Anupriya Chhabra, i dr.
Izdano: (2022-11-01)

A Quantitative <sup>1</sup>H NMR Method for Screening Cannabinoids in CBD Oils
od: Ines Barthlott, i dr.
Izdano: (2021-06-01)

Whole Blood Metabolomic Profiling of Mice with Tacrolimus-Induced Chronic Nephrotoxicity: NAD<sup>+</sup> Depletion with Salvage Pathway Impairment
od: Sho Nishida, i dr.
Izdano: (2025-01-01)

Heterotridentate Organomonophosphines in Pt(κ<sup>3</sup>–X<sup>1</sup>P<sup>1</sup>X<sup>2</sup>)(Y) (X<sup>1,2</sup> = N<sup>1,2</sup> or S<sup>1,2</sup>), Pt(κ<sup>3</sup>–P<sup>1</sup>N<sup>1</sup>X<sup>1</sup>)(Y) (X<sup>1</sup> = O, C, S or Se) Pt(κ<sup>3</sup>–P<sup>1</sup>S<sup>1</sup>Cl<sup>1</sup>)(Cl) and Pt(κ<sup>3</sup>–P<sup>1</sup>Si<sup>1</sup>N<sup>1</sup>)(OL)—Structural Aspects
od: Milan Melník, i dr.
Izdano: (2022-12-01)

Na<sup>+</sup>,K<sup>+</sup>-ATPase with Disrupted Na<sup>+</sup> Binding Sites I and III Binds Na<sup>+</sup> with Increased Affinity at Site II and Undergoes Na<sup>+</sup>-Activated Phosphorylation with ATP
od: Hang N. Nielsen, i dr.
Izdano: (2024-01-01)

Single-Center Comparison of [<sup>64</sup>Cu]-DOTAGA-PSMA and [<sup>18</sup>F]-PSMA PET–CT for Imaging Prostate Cancer
od: Siroos Mirzaei, i dr.
Izdano: (2021-10-01)

<sup>13</sup>C NMR Dataset Qualitative Analysis of Grecian Wines
od: Alberto Mannu, i dr.
Izdano: (2020-09-01)

Roles of NAD<sup>+</sup> and Its Metabolites Regulated Calcium Channels in Cancer
od: Peilin Yu, i dr.
Izdano: (2020-10-01)

<sup>177</sup>Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
od: Yasemin Sanli, i dr.
Izdano: (2021-04-01)

Nuclear Cross-Section of Proton-Induced Reactions on Enriched <sup>48</sup>Ti Targets for the Production of Theranostic <sup>47</sup>Sc Radionuclide, <sup>46c</sup>Sc, <sup>44m</sup>Sc, <sup>44g</sup>Sc, <sup>43</sup>Sc, and <sup>48</sup>V
od: Liliana Mou, i dr.
Izdano: (2023-12-01)

Bacteria-Infected Artificial Urine Characterization Based on a Combined Approach Using an Electronic Tongue Complemented with <sup>1</sup>H-NMR and Flow Cytometry
od: Carolin Psotta, i dr.
Izdano: (2023-10-01)

<sup>18</sup>F-FDG PET Is Not Inferior to <sup>68</sup>Ga-PSMA PET for Detecting Biochemical Recurrent Prostate Cancer with a High Gleason Score: A Head-to-Head Comparison Study
od: Lian Xu, i dr.
Izdano: (2023-12-01)

Activity concentrations of <sup>60</sup> Co, <sup>137</sup>Cs and <sup>241</sup>Am in sieved soil and soil inclusions from the «Taiga» peaceful nuclear explosions site
od: V. P. Ramzaev, i dr.
Izdano: (2024-10-01)

<sup>1</sup>H-NMR Spectroscopy Coupled with Chemometrics to Classify Wines According to Different Grape Varieties and Different Terroirs
od: Paola Bambina, i dr.
Izdano: (2024-05-01)

Optimized Therapeutic <sup>177</sup>Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer
od: Yitian Wu, i dr.
Izdano: (2022-12-01)

Study of the Reactivity of Lignin Model Compounds to Fluorobenzylation Using <sup>13</sup>C and <sup>19</sup>F NMR: Application to Lignin Phenolic Hydroxyl Group Quantification by <sup>19</sup>F NMR
od: Esakkiammal Sudha Esakkimuthu, i dr.
Izdano: (2020-07-01)

[<sup>18</sup>F]fluciclovine vs. [<sup>18</sup>F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
od: Cristina Ferrari, i dr.
Izdano: (2022-11-01)

Organomonophosphines in Pt(η<sup>3</sup>-X<sup>1</sup>X<sup>2</sup>X<sup>3</sup>)(PR<sub>3</sub>), (X = N<sup>1</sup>, N<sup>2</sup>, N<sup>3</sup>; S<sup>1</sup>, S<sup>2</sup>, S<sup>3</sup>; or Te<sup>1</sup>, Te<sup>2</sup>, Te<sup>3</sup>) Derivatives: Structural Aspects
od: Milan Melník, i dr.
Izdano: (2023-06-01)